Nurse Practitioner, Family · Everett, PA
NPI
1174084339
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
300 N Spring St
Everett, PA, 15537
Phone (814) 652-5133
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
1,473 services
Medicare patients, 2024
85
Average age 72
Drug cost, 2024
$1.2M
5,197 prescriptions
Company payments, 2025
$4,917
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tammie Payne was code 99214 (office e&m - established), 174 times for 76 patients. In total Tammie Payne billed 1,473 services in 20 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 174 | 76 | $71.88 | $13K |
| 95251 Test - Miscellaneous | Office | 65 | 35 | $21.46 | $1,395 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 51 | 34 | $10.25 | $523 |
By year: 2022 $15K for 271 services; 2023 $16K for 280 services; 2024 $22K for 1,473 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tammie Payne prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 206 prescriptions and refills. In total Tammie Payne wrote 5,197 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 206 | 296 | 37 | $167K |
| Atorvastatin Calcium Generic | 184 | 424 | 43 | $2,387 |
| Levothyroxine Sodium Generic | 167 | 367 | 34 | $1,822 |
| Metformin Hcl Er Metformin Hcl | 159 | 357 | 36 | $2,455 |
| Ozempic Semaglutide | 138 | 162 | 23 | $144K |
| Pantoprazole Sodium Generic | 111 | 223 | 25 | $1,563 |
| Trulicity Dulaglutide | 106 | 111 | 14 | $103K |
| Humalog Insulin Lispro | 105 | 124 | 23 | $19K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 104 | 166 | 26 | $13K |
| Metformin Hcl Generic | 103 | 221 | 24 | $837 |
| Amlodipine Besylate Generic | 103 | 217 | 23 | $662 |
| V-Go 40 Sub-Q Insulin Device, 40 Unit | 101 | 109 | 12 | $53K |
| Gabapentin Generic | 100 | 162 | 20 | $1,435 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 99 | 140 | 17 | $101K |
| Mounjaro Tirzepatide | 93 | 110 | 15 | $111K |
Brand drugs: 1,579 claims; generic drugs: 3,257 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tammie Payne $4,917 ($4,917 in general payments such as food, travel and fees) from 16 companies. The largest payer was Mannkind Corporation with $1,572.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 3 | $1,572 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $1,482 |
| Beta Bionics, Inc. BBNX | 3 | $265 |
| Lilly USA, LLC LLY | 3 | $252 |
| Boston Scientific Corporation BSX | 2 | $223 |
| Insulet Corporation PODD | 1 | $175 |
| Medtronic, Inc. MDT | 1 | $150 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $146 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.